Australian Prescriber An independent Review Logo

All Issues

Volume
 

IF YOU PRESCRIBE SUBSCRIBE

If you're a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe
  • empty

    Volume 49 Issue 2

    April 2026
  • April 2026

Metabolic dysfunction–associated fatty liver disease: an update

Metabolic dysfunction–associated fatty liver disease: an update
Article Richard O’Halloran, Leon A Adams, Gary Deed, John S Lubel
  • 7 April 2026
    • CPD for GPs

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common and growing cause of liver cirrhosis, hepatocellular carcinoma and reason for liver transplantation. This article outlines an approach to diagnosing and managing MAFLD, particularly in primary care.
Article

Measuring blood pressure accurately

Anastasia S Mihailidou
  • 7 April 2026
  • CPD for GPs
Article

Vitamin B12 deficiency: testing and treatment

Darya Bedz, Cecily Forsyth
  • 7 April 2026
  • CPD for GPs
Article

Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals

Lisa Hui, Natasha E Holmes, Michelle L Giles, William Rawlinson
  • 7 April 2026
  • CPD for GPs
Medication Mishap

Toxic interaction between atorvastatin and clarithromycin causing myositis and rhabdomyolysis

Mitchel Hurlbert, Tien Tay, Cameron J Holloway, Laila Girgis
  • 7 April 2026
  • CPD for GPs
Letter to the Editor

Sunscreen, vitamin D and skin of colour

Rachel E Neale, David C Whiteman, Samuel Morriss, Laura Scardamaglia
  • 7 April 2026
TGA Medicines Safety Update summary

Medicines containing vitamin B6 (pyridoxine, pyridoxal or pyridoxamine)

  • 7 April 2026
NEW DRUGS

Adrenaline (epinephrine) nasal spray for severe allergic reactions

  • 7 April 2026

Foslevodopa+foscarbidopa for advanced Parkinson disease

  • 7 April 2026

IF YOU PRESCRIBE SUBSCRIBE

If you're a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe